Characterization of a Newly Synthesized Cysteinyl Leukotriene 2 Receptor Selective Antagonist Using Cell Based β-arrestin and Vascular Ear Permeability Assays in Mice
(hCysLT2R) based on a β-galactosidase complementation system. The EC50 values for LTC4 and LTD4 are consistent with previous literature values determined based on radio-labelling affinity assays for hCysLT2R. Activity of a synthetic analogue of LTC4, N-Methyl LTC4 (NMLTC4), gave an EC50 value of 8.5...
Main Author: | YAN, DONG |
---|---|
Other Authors: | Queen's University (Kingston, Ont.). Theses (Queen's University (Kingston, Ont.)) |
Language: | en en |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/1974/6597 |
Similar Items
-
Involvement of the cysteinyl-leukotrienes in coronary artery disease
by: Shah, Duniya
Published: (1997) -
Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
by: Gregory R. Tintinger, et al.
Published: (2010-01-01) -
Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
by: A. J. Theron, et al.
Published: (2014-01-01) -
Cysteinyl-Leukotriene Receptors and Cellular Signals
by: G. Enrico Rovati, et al.
Published: (2007-01-01) -
The role of cysteinyl-leukotriene receptors in asthma
by: Hao, Lanping
Published: (2003)